—NKE
— • —
$42.62
P/E
28.04
PEG
—
FCF Yield
—
Rev Growth YoY
-271.0% YoY
Gross Margin
4081.0%
Health Score
5/10
D/E Ratio
0.60
Confidence
LOW
Business Snapshot
The ticker and exchange identifiers were not supplied in this data payload, which prevents a full company description. Based on the available financial profile — a current price of $42.62, a Price/Sales ratio of 1.36x, and a P/E of 28.04x — this appears to be an operating company with meaningful revenue-generating activity. Without a confirmed market capitalisation figure, the cap-tier classification cannot be established with certainty.
Financial Health
**Score: 5/10** The balance sheet shows a manageable debt load with a Debt/Equity ratio of 0.6x and a healthy current ratio of 2.21x, suggesting the company can comfortably cover near-term obligations. However, the absence of free cash flow data is a meaningful transparency gap that limits confidence in the quality of earnings...
Risk Assessment
- **DATA INTEGRITY:** Gross margin of 4,081% and net margin of 484% are statistically implausible for a normal operating business and likely signal a one-time accounting event, restatement, or data error that distorts all margin-based analysis. - **REVENUE DECLINE:** Revenue growth of -271% year-over-year indicates a reversal or collapse in the top line, not merely a slowdown. - **EARNINGS DETERIORATION:** Earnings growth of -4,942% year-over-year represents an extraordinary breakdown in profitability, regardless of the unusual margin figures. - **VALUATION STRETCH:** EV/EBITDA of 61.57x is highly elevated and difficult to justify against a backdrop of declining revenues and uncertain cash generation. - **CASH FLOW OPACITY:** Free cash flow is unavailable, making it impossible to assess whether reported earnings translate into real cash generation — a critical unknown for any valuation exercise. ---...